<DOC>
	<DOCNO>NCT02054715</DOCNO>
	<brief_summary>This randomize clinical trial compare multimedia psychoeducation print education prepare patient cancer decision make clinical trial participation . Multimedia psychoeducation include DVD write material combine focus knowledge attitude change , may effective method help patient prepare decision make clinical trial participation . It yet know whether multimedia psychoeducation effective print education prepare patient decision make clinical trial .</brief_summary>
	<brief_title>Multimedia Psychoeducation Print Education Preparing Cancer Patients Decision Making About Clinical Trial Participation</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine effect intervention assignment patient ' preparedness decision make clinical trial participation . SECONDARY OBJECTIVES : I . To determine effect intervention assignment indicator quality patient ' decision make clinical trial participation . II . To examine mechanisms multimedia psychoeducation ( MP ) exert expect positive effect preparedness decision making . TERTIARY OBJECTIVES : I . To explore effect intervention assignment clinical trial participation . OUTLINE : Participants randomize 1 2 arm . ARM I : Participants undergo print educational intervention meet site coordinator instruct read National Cancer Institute ( NCI ) booklet title Taking Part Cancer Treatment Studies , comprise primarily information nature conduct cancer clinical trial . ARM II : Participants undergo multimedia psychoeducational intervention meet site coordinator instructed view digital video disk ( DVD ) read booklet title Clinical Trials : Are They Right For You ? Participants encourage watch DVD read booklet home . After completion study , patient follow 3-7 49-56 day .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Be able speak read English Be diagnose cancer Have inform eligibility specific phase II III therapeutic clinical trial open enrollment participate NCI Community Oncology Research Program ( NCORP ) site Have already meet one eligibility criterion reasonable expectation meeting remain eligibility criterion therapeutic clinical trial Be capable provide write informed consent study participation Participants must ask previously participate another therapeutic cancer clinical trial Participants must already make decision participate phase II III therapeutic clinical trial inform eligibility Participants must document observable visual , auditory , psychiatric , neurological disorder would interfere study participation ( e.g. , blindness , deafness , psychosis , dementia ) Participants must eligible phase I trial ; patient exclude trial offer NCORP site design goal differ considerably phase II III trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>